INNOV LABS
INNOV LABS is an AI-native drug discovery and pharmaceutical R&D platform company offering an Electronic Lab Notebook, multi-omics analysis, and AI-driven scientific reporting for biotech, pharma, hospitals, CROs, and academic research institutions. Headquartered in Texas with a delivery office in India.
- Company typePrivate
- Founded2024
- HeadquartersCypress, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What INNOV LABS does
INNOV LABS is a privately-held AI drug discovery and pharmaceutical R&D technology company headquartered in Houston, Texas, with a secondary office in Hyderabad, India, operating through US entity Innov Labs (Texas) and India entity Innov Labs India (Telangana). The company builds an AI-native Electronic Lab Notebook (ELN) platform that combines structured experiment documentation, scalable biological data analysis, and automated reporting, powered by domain-tuned Graph Neural Networks and Transformers for multi-omics analysis, predictive modeling, hit-to-lead identification, and ADMET prediction. The platform supports genomics, proteomics, chemistry, and clinical data, with NLP over biomedical literature, computer vision for high-content screening and Cryo-EM, and explainable AI for biological interpretability, all delivered on a cloud-native architecture spanning Azure, AWS, and GCP with deployment options including dedicated VPC and on-premises.
The product portfolio is organized as a unified stack: the AI Platform for Scientific Data Analysis and Reporting, the ELN, the Biological Data Analysis Engine, and Scientific Reporting and Insights. Complementary service lines include Chemical R&D, Biotech and Life Sciences, Drug Discovery and Development, Clinical Trial Scientific Services, and ML and AI Solutions, delivered through fractional scientist retainers, project-based engagements, embedded scientific teams, and expert advisory models. The company maintains HIPAA, GDPR, ISO, and 21 CFR Part 11 compliance, is pursuing AICPA SOC 2 Type 2, and is a member of the NVIDIA Inception Program.
Commercially, INNOV LABS operates a hybrid go-to-market with a sales-led enterprise motion (Request a Demo, Schedule Demo Session, Contact Sales) for pharma, biotech, and healthcare buyers, alongside a product-led growth motion offering a free trial with no credit card required. Pricing is tiered across Research Teams, Growth and Innovation, and Enterprise subscriptions, with billing on monthly, annual, and multi-year cadences; pricing is not publicly disclosed. The customer base spans biotech and pharma R&D teams, hospitals and health systems, contract research organizations, university labs, and innovation and discovery teams, with about 25 named strategic partners (5 hospitals, 12 biotech companies, 8 academic institutions). No funding rounds, investors, or revenue figures are publicly disclosed.
INNOV LABS firmographics
Firmographics- Name
- INNOV LABS
- Legal name
- Innov Labs
- Website
- https://innovlabs.ai
- Company type
- Private
- Founded year
- 2024
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- INNOV LABS is an AI-native drug discovery and pharmaceutical R&D platform company offering an Electronic Lab Notebook, multi-omics analysis, and AI-driven scientific reporting for biotech, pharma, hospitals, CROs, and academic research institutions. Headquartered in Texas with a delivery office in India.
- Ownership category
- akta.pro rank
INNOV LABS industry classification
Industry- Product category
- AI Drug Discovery Platform
- NAICS
- Custom Computer Programming Services (541511), Other Scientific and Technical Consulting Services (541690)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Computer Programming Services (7371)
- akta.pro primary industry
- Electronic Lab Notebooks (ELN) (HLAGAJAB)
- akta.pro secondary industries
- Bioinformatics & Multi-omics Analysis Software (HLAGAJAD), AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO), Knowledge Management & Scientific Collaboration / Literature Intelligence (HLAGAJAN)
Keywords
Where INNOV LABS is headquartered
LocationHeadquarters
- HQ city
- Cypress
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
INNOV LABS business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Revenue model
- SaaS Platform Subscriptions: Tiered SaaS subscriptions (Research Teams, Growth and Innovation, Enterprise) with advanced features at higher tiers. Cloud-based delivery with compliance controls and API integrations
- Professional Services: Scientific professional services including Chemical R&D consulting, Biotech & Life Sciences services, Drug Discovery services, Clinical Trial services, ML & AI solutions, and Custom Research & Consultation
- Consulting Engagement Models: Flexible engagement models including Fractional Scientist Retainer, Project-Based Engagement, Embedded Scientific Team, Expert Review & Advisory, and AI-Augmented Research Support
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Research Teams - ELN functionality for academic labs and small research groups |
| Subscription | Annual | Growth and Innovation - For growing biotech and mid-sized R&D teams |
| Subscription | Multi-year contract | Enterprise - For pharma, healthcare, and large-scale R&D corporations |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
INNOV LABS product offering
Product offeringCore offering
INNOV LABS provides an AI-native Electronic Lab Notebook (ELN) platform that combines structured experiment documentation, scalable biological data analysis using domain-tuned Graph Neural Networks (GNNs) and Transformers, and automated scientific reporting for pharmaceutical, biotech, healthcare, and academic research organizations. The platform is delivered as a tiered SaaS subscription (Research Teams, Growth and Innovation, Enterprise) with 21 CFR Part 11, HIPAA, GDPR, ISO, and SOC 2 compliance. In addition to the platform, INNOV LABS offers professional scientific services covering Drug Discovery & Development, Clinical Trial Scientific Services, Biotech & Life Sciences, Chemical R&D, and ML & AI Solutions delivered through fractional, project-based, and embedded engagement models.
Product overview
INNOV LABS offers a unified AI-native ELN (Electronic Lab Notebook) platform called Innovlabs.ai, which combines AI, analytics, and documentation for scientific research. The core product portfolio includes the AI Platform for Scientific Data Analysis & Reporting, Electronic Lab Notebook (ELN), Biological Data Analysis Engine, Scientific Reporting & Insights, and Cloud-Based Analytics Platform. These products work together as a cohesive system: the ELN captures structured experiments and protocols, the Biological Data Analysis Engine processes multi-omics data using GNNs and transformers, and the Scientific Reporting module generates publication-ready outputs. In addition to the platform, INNOV LABS provides professional services including Chemical R&D, Biotech & Life Sciences, Drug Discovery & Development, Clinical Trial Scientific Services, and ML & AI Solutions, delivered through various engagement models such as fractional scientist retainers, project-based engagements, embedded scientific teams, and expert reviews.
Differentiator
Problem solved
Functional benefit
Products and services
- AI Platform for Scientific Data Analysis & Reporting A unified cloud platform that combines structured experiment documentation, scalable biological data analysis, and automated reporting, enabling research teams to move from raw data to decision-ready insights in one system. Designed for biotech, pharma, healthcare, and academic research organizations.
- Electronic Lab Notebook (ELN) A secure, compliant Electronic Lab Notebook for structured experiment capture with AI-assisted documentation, improving reproducibility, traceability, and collaboration. Features 21 CFR Part 11 compliant e-signatures and blockchain integration for IP protection.
- Cloud-Based Analytics Platform High-performance biocomputing with scalable, secure cloud infrastructure supporting petabyte-scale datasets, real-time data processing, and collaborative research with granular access controls.
- Drug Discovery & Development Services Expert scientific consulting for target identification, hit-to-lead and lead optimization, DMPK and ADMET study design, and preclinical program and IND-enabling study management. For pharma and biotech organizations.
- Chemical R&D Services Expert scientific consulting for synthetic route development, compound characterization, process chemistry, and computational chemistry including molecular modeling and QSAR analysis.
- Biotech & Life Sciences Services Biological research design, genomics and sequencing data interpretation, protein science advisory, CRISPR and gene editing program support, and bioprocess development consulting.
- Clinical Trial Scientific Services Clinical protocol design, biomarker strategy and translational science, clinical data review and interim analysis support, and regulatory submission and medical writing.
- ML & AI Solutions Predictive modeling, NLP for bioinformatics, AI-powered drug discovery, genetic data analysis, and custom AI solutions including computer vision for high-content screening and Cryo-EM processing.
Quantifiable outcome
- Accelerates drug discovery with lead-ready AI insights
- +2 more outcomes
Companies that use INNOV LABS
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles5 records
INNOV LABS technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature7 records
INNOV LABS partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- NVIDIAcoreNVIDIA Inception Program member providing AI and deep learning infrastructure capabilities. NVIDIA partnership enables advanced GPU computing for AI model training and inference in drug discovery workflows.
Scale indicators4 records
Recent moves6 records
Expansion highlights7 records
INNOV LABS competitors and assessment
Company assessmentEmerging players
- Recursion Pharmaceuticals: AI-driven drug discovery company combining high-content screening, computer vision, and machine learning. Partial overlap with Innov Labs' AI-powered drug discovery, multi-omics, and computer vision capabilities.
- TetraScience: Scientific data cloud platform that ingests lab instrument data and harmonizes it for analytics and AI. Comparable to Innov Labs in the data platform and LIMS integration layer of its enterprise offering.
- Insitro: Machine learning-driven drug discovery platform focused on predictive modeling for disease and therapeutic response. Comparable to Innov Labs' predictive modeling, multi-omics, and AI drug discovery modules.
Direct peers
- LabVantage Solutions: Enterprise LIMS and ELN vendor with strong presence in regulated pharma and clinical labs. Directly comparable on ELN functionality and instrument integration available in Innov Labs' Enterprise tier.
- Sapio Sciences: Unified lab informatics platform combining ELN, LIMS, and scientific data management with low-code configuration. Directly comparable on the ELN + LIMS + data platform bundle that Innov Labs packages for enterprise pharma.
- Benchling: Cloud-native R&D platform combining ELN, LIMS, molecular biology, and registry capabilities targeted at biotech and pharma R&D teams. Most direct comparably positioned competitor to Innov Labs' AI-native ELN with structured experiment capture and downstream analysis.
- LabArchives: Widely adopted SaaS ELN serving academic and commercial research labs with structured experiment documentation and collaboration. Directly competes in the ELN tier of Innov Labs' offering, particularly for academic and small biotech customers.
Broad incumbents
- Schrödinger: Computational chemistry and molecular simulation platform with deep drug-discovery use cases across pharma. Overlaps with Innov Labs on AI/ML-driven lead identification and ADMET prediction for biotech and pharma customers.
- Veeva Systems: Life sciences cloud platform spanning clinical, regulatory, quality, and commercial functions for pharma. Adjacent incumbent that touches clinical trial, regulatory, and quality workflows where Innov Labs positions its clinical trial scientific services.
- Dotmatics: Enterprise scientific informatics platform offering ELN, LIMS, data management, and analysis for life sciences R&D. Broader incumbent with deeper enterprise footprint; competes directly with Innov Labs in pharma ELN and data capture.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
INNOV LABS social profiles
Digital presenceINNOV LABS compliance and trust
Trust signalCompliance5 records
INNOV LABS financial estimates
Financial estimateRevenue estimate
Valuation estimate
INNOV LABS leadership team
Management profileNumber of profiles
INNOV LABS funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
INNOV LABS M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about INNOV LABS
What does INNOV LABS do?
INNOV LABS provides an AI-native Electronic Lab Notebook (ELN) platform that combines structured experiment documentation, scalable biological data analysis using domain-tuned Graph Neural Networks (GNNs) and Transformers, and automated scientific reporting for pharmaceutical, biotech, healthcare, and academic research organizations. The platform is delivered as a tiered SaaS subscription (Research Teams, Growth and Innovation, Enterprise) with 21 CFR Part 11, HIPAA, GDPR, ISO, and SOC 2 compliance. In addition to the platform, INNOV LABS offers professional scientific services covering Drug Discovery & Development, Clinical Trial Scientific Services, Biotech & Life Sciences, Chemical R&D, and ML & AI Solutions delivered through fractional, project-based, and embedded engagement models.
Is INNOV LABS a public or private company?
INNOV LABS is a private company. It is classified as unknown and is currently operating.
When was INNOV LABS founded?
INNOV LABS was founded in 2024. It employs 11 to 50 people.
Where is INNOV LABS based?
INNOV LABS is headquartered in Cypress, United States, in the North America region.
How does INNOV LABS make money?
Three revenue lines are on record. SaaS Platform Subscriptions are the primary driver. The others are professional Services and consulting Engagement Models.
Who are INNOV LABS's main competitors?
Emerging players on record are Recursion Pharmaceuticals, TetraScience and Insitro. Direct peers are LabVantage Solutions, Sapio Sciences, Benchling and LabArchives. Broad incumbents are Schrödinger, Veeva Systems and Dotmatics.
Does INNOV LABS have an API?
Yes. Custom API and instrument integration is available as part of the Enterprise pricing tier. The platform supports integration with LIMS (Laboratory Information Management Systems) and other enterprise systems using secure APIs and flexible integration frameworks. Available via dedicated Virtual Private Cloud or secure on-premises/private networks deployment options.
What industry is INNOV LABS in?
INNOV LABS's product category is AI Drug Discovery Platform. Its primary akta.pro industry code is HLAGAJAB, Electronic Lab Notebooks (ELN), with a secondary code of HLAGAJAD, Bioinformatics & Multi-omics Analysis Software. Its NAICS code is 541511 and its SIC code is 8731.